{
    "title": "Bristol Myers looks to new CEO as competition from generic drugs heats up",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12020931/Bristol-Myers-looks-new-CEO-competition-generic-drugs-heats-up.html",
    "date": "2023-04-27",
    "keywords": [
        "company",
        "boerner",
        "competition",
        "drug",
        "revlimid",
        "quarter",
        "year",
        "giovanni",
        "caforio",
        "officer",
        "thursday",
        "cancer",
        "revenue",
        "exclusivity",
        "bristol",
        "seigerman",
        "reporting",
        "ceo",
        "november",
        "commercialization",
        "chris",
        "drugmaker",
        "topselling",
        "firstquarter",
        "demand",
        "generic",
        "immunotherapy",
        "opdivo",
        "blood",
        "thinner",
        "decade",
        "shift",
        "execution",
        "launch",
        "growth",
        "face",
        "patent",
        "analyst",
        "evan",
        "note",
        "discount",
        "expansion",
        "heart",
        "disease",
        "camzyos",
        "psoriasis",
        "sotyktu",
        "job",
        "leadership",
        "inc",
        "foundation",
        "value",
        "interview",
        "executive",
        "chairman",
        "cfo",
        "david",
        "impact",
        "exchange",
        "premarket",
        "trade",
        "forecast",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "diane",
        "craft",
        "bhattacharjee"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}